Personal-Care Firms: Don’t Be “Sitting Duck” For Calif. Consumer Regs
This article was originally published in The Rose Sheet
Personal care marketers should develop a precautionary regulatory compliance strategy in case they are targeted in the next round of California’s Safer Consumer Products Regulations, says Alston & Bird LLP partner Maureen Gorsen. Marketers should anticipate which of their product/ingredient combinations are most likely to draw red flags, and have a supplier training and communication plan in place.
You may also be interested in...
Clif Bar didn’t convince National Advertising Division a challenge by Kind is too “complex” for the SWIFT forum. NAD attorneys determined Clif didn’t support its claims of sustained energy and “better” performing ability.
Although Washington Homeopathic informed FDA it recalled homeopathics manufactured by a supplier on import alert and would recall “high risk” tinctures, it would allow its customers to decide whether to return other products also identified as potentially adulterated.
FDA warns Florida firm Modern Allergy Management and a testing lab abut an unapproved and mislabeled home-use fingerstick sample collection for COVID-19 test. The firm promised results within three days.